Xgene Pharmaceutical Inc. was incorporated in Cayman Islands in November 2015 and is utilizing its small molecule discovery and development capabilities to create innovative ''dual-acting'' drug conjugates for treatment of acute pain, chronic pain and infectious diseases. In medicine, there is rarely a single pill or a ''silver bullet'' that treats all.  By identifying multiple medications whose mechanisms work together in a complementary or even synergistic manner, Xgene Pharmaceutical Inc. aims to improve the patient treatment outcomes while potentially reducing the complexity and the risks of the current therapy.